Notice of Intent to Sole Source - Minneapolis VA Medical Center - FDA-Approved CEDIA... Tender

Procurement Summary

Country : USA

Summary : Notice of Intent to Sole Source - Minneapolis VA Medical Center - FDA-Approved CEDIA and DRI Drugs of Abuse Reagents, Calibrators, and Controls for Assays used with Beckman AU480 Analyzers

Deadline : 18 Sep 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 107091772

Document Ref. No. : 36C26324Q1195

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Login to see details

Tender Details

Description

Presolicitation NoticePresolicitation NoticePage 3 of 7Presolicitation Notice*=Required FieldPresolicitation NoticePage 1 of 7This Notice of Intent is provided to advise that the Government intends to solicit and negotiate a sole source, Firm Fixed Price contract with option periods with only one source, Microgenics Corporation, to provide FDA-Approved CEDIA and DRI Drugs of Abuse Reagents, Calibrators, and Controls for Assays used with Beckman AU480 Analyzers for the Minneapolis VA Medical Center. This contract action is for supplies for which the Government intends to solicit and negotiate a Sole Source award under the authority of FAR 13.106-1.This notice of intent to award a sole source contract is not a request for competitive proposals. However, in accordance with FAR 5.207 (c) (16) (ii), all responsible sources that feel they can meet the Government s requirements detailed above may submit a capability statement which shall be considered by the agency. Responses to this notice shall contain sufficient information to establish the interested parties bona-fide capabilities for fulfilling the requirement and include: the System for Award Management (SAM) Unique Entity ID (UEI), and the Taxpayer Identification Number (TIN), along with documentation that the vendor is an authorized distributor/reseller. All offerors must have an active registration in SAM at www.sam.gov. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information will be retained as Market Research. All responses must be received by 12:00 PM Central Time on Wednesday, September 18, 2024.Responses shall be submitted electronically to Alisha Milander via email at Alisha.Milander@va.gov. Fax responses and Telephone inquiries will not be accepted.
Active Contract Opportunity
Notice ID : 36C26324Q1195
Related Notice
Department/Ind. Agency : VETERANS AFFAIRS, DEPARTMENT OF
Sub-tier : VETERANS AFFAIRS, DEPARTMENT OF
Office: NETWORK CONTRACT OFFICE 23 (36C263)
General Information
Contract Opportunity Type: Presolicitation (Original)
All Dates/Times are: (UTC-05:00) CENTRAL STANDARD TIME, CHICAGO, USA
Original Published Date: Sep 11, 2024 01:18 pm CDT
Original Response Date: Sep 18, 2024 12:00 pm CDT
Inactive Policy: Manual
Original Inactive Date: Oct 02, 2024
Initiative: None

Classification
Original Set Aside:
Product Service Code: 6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
NAICS Code: 325413 - In-Vitro Diagnostic Substance Manufacturing

Place of Performance: Minneapolis VA Medical Center Minneapolis, MN 55417 USA

Documents

 Tender Notice

36C26324Q1195.docx